Bastiaan Sallevelt

375 Detectability of medication errors in older people prior to potentially preventable admissions 42. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008. https://doi. org/10.1111/j.1751-7176.2008.07572.x. 43. Barthel D, Mahoney F. Functional evaluation: The Barthel Index. Md State Med J 1965;14:61–5. 44. Uitvlugt EB, Janssen MJA, Siegert CEH, Kneepkens EL, van den Bemt BJF, van den Bemt PMLA, et al. Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors. Front Pharmacol 2021;12:1–9. https://doi.org/10.3389/fphar.2021.567424. 45. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: A systematic review of observational studies. PLoS One 2014;9:3–11. https://doi.org/10.1371/journal. pone.0102149. 46. Pippins JR, Gandhi TK, Hamann C, Ndumele CD, Labonville SA, Diedrichsen EK, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med 2008;23:1414–22. https://doi.org/10.1007/s11606-008-0687-9. 47. Vira T, Colquhoun M, Etchells E. Reconcilable differences: Correcting medication errors at hospital admission and discharge. Qual Saf Heal Care 2006. https://doi.org/10.1136/ qshc.2005.015347. 48. Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/ START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs and Aging 2021;39:59–73. https://doi.org/10.1007/s40266-021-00904-z. 49. Dalton K, Curtin D, O’Mahony D, Byrne S. Computer-generated STOPP/START recommendations for hospitalised older adults: evaluation of the relationship between clinical relevance and rate of implementation in the SENATOR trial. Age Ageing 2020;49:615–21. https://doi.org/10.1093/ageing/afaa062. 50. Verdoorn S, Kwint HF, Faber A, Gussekloo J, Bouvy ML. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria. Eur J Clin Pharmacol 2015;71:1255–62. https://doi.org/10.1007/s00228-0151908-x. 51. Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol 2018;74(6):679–700. https://doi.org/10.1007/s00228-018-2446-0. 52. Perpétuo C, Plácido AI, Rodrigues D, Aperta J, Piñeiro-Lamas M, Figueiras A, et al. Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria. Front Pharmacol 2021;12:1–11. https://doi.org/10.3389/ fphar.2021.676020. 53. Sallevelt BTGM, Huibers CJA, Knol W, Puijenbroek E Van, Egberts T, Wilting I. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: A quality appraisal study. BMJ Open 2020;10:1–8. https://doi.org/10.1136/ bmjopen-2019-033721. 54. Huibers CJA, Sallevelt BTGM, Heij JMJ op, O’Mahony D, Rodondi N, Dalleur O, et al. Hospital physicians’ and older patients’ agreement with individualised STOPP/STARTbased medication optimisation recommendations in a clinical trial setting. Eur Geriatr Med 2022;13:541–52. https://doi.org/10.1007/s41999-022-00633-5. 4

RkJQdWJsaXNoZXIy MTk4NDMw